1. Home
  2. ARDX

ARDX

Ardelyx Inc.

Logo Ardelyx Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 3:58pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Founded: 2007 Country:
United States
United States
Employees: N/A City: FREMONT
Market Cap: 1.5B IPO Year: 2014
Target Price: $12.69 AVG Volume (30 days): 5.5M
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.30 EPS Growth: N/A
52 Week Low/High: $3.16 - $10.13 Next Earning Date: 05-02-2024
Revenue: $124,456,000 Revenue Growth: 138.61%
Revenue Growth (this year): 71.54% Revenue Growth (next year): 73.15%

Share on Social Networks: